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Titanium dioxide nanoparticles (TiO2-NPs, <100 nm) are increasingly being used in phar-
maceuticals and cosmetics due to the unique properties derived from their small sizes.
However, their large surface-area to mass ratio and high redox potential may negatively
impact human health and the environment. TiO2-NPs can cause inflammation, pulmonary
damage, fibrosis, and lung tumors and they are possibly carcinogenic to humans. Because
cancer is a disease involving mutation, there are a large number of studies on the geno-
toxicity of TiO2-NPs. In this article, we review the results that have been reported in the
literature, with a focus on data generated from the standard genotoxicity assays. The data
include genotoxicity results from the Ames test, in vitro and in vivo Comet assay, in vitro
and in vivo micronucleus assay, sister chromatid exchange assay, mammalian cell
hypoxanthine-guanine phosphoribosyl transferase gene assay, the wing somatic mutation
and recombination assay, and the mouse phosphatidylinositol glycan, class A gene assay.
Inconsistent results have been found in these assays, with both positive and negative re-
sponses being reported. The in vitro systems for assessing the genotoxicity of TiO2-NPs
have generated a greater number of positive results than the in vivo systems, and tests for
DNA and chromosome damage have produced more positive results than the assays
measuring gene mutation. Nearly all tests for measuring the mutagenicity of TiO2-NPs
were negative. The current data indicate that the genotoxicity of TiO2-NPs is mediated
mainly through the generation of oxidative stress in cells.
Copyright ª 2014, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.Open access under CC BY-NC-ND license. 1. Introduction
Titanium dioxide (TiO2) is the naturally occurring oxide of ti-
tanium. It has several different crystalline structures. Rutile is
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[2]. Until recently, the use had been limited to coarse and fine
(both diameters > 100 nm) TiO2 particles. Coarse and fine
particles of TiO2 have been investigated and declared biolog-
ically inert in humans and animals [3,4]. More recently, TiO2
nanoparticles (TiO2-NPs, <100 nm) have increasingly been
used in pharmaceuticals and cosmetics due to the unique
properties derived from their small sizes [5,6]. These new
applications of TiO2-NPs, however, call into question their
biological inertness.
TiO2-NPs have a large surface-area to mass ratio [7] and a
high redox potential, which can cause undesirable effects on
human health and the environment. Recent studies have
revealed that exposure to TiO2-NPs can cause inflammation,
pulmonary damage, fibrosis, and lung tumors in rodents
[7e9]. TiO2-NPs are possibly carcinogenic to humans (Group
2B) based on sufficient evidence in experimental animals and
inadequate evidence from epidemiology studies, according to
a report from the International Agency for Research on Cancer
[10]. The National Institute for Occupational Safety and Health
(NIOSH) [11] also concluded that TiO2-NPs were a potential
occupational carcinogen, acting through a secondary geno-
toxicity mechanism primarily related to particle size and
surface area.
Genotoxicity data are important for nanotechnology
regulation and risk assessment. Recently, the genotoxicity of
TiO2-NPs has been intensively studied due to their carcino-
genicity. Although a large number of reports on the genotox-
icity of TiO2-NPs and its underlying mechanisms have been
published, there has been no review article specific to the
genotoxicity of TiO2-NPs. The purpose of this review is to
present up-to-date knowledge regarding the genotoxicity of
TiO2-NPs, with a focus on results from standard genotoxicity
assays.2. In vitro studies
Results on genotoxicity studies on TiO2-NPs were identified
throughMedline database searches. The data from the studies
using the standard genotoxicity assays including the Ames
test, Comet assay, micronucleus assay, sister chromatid ex-
change (SCE) assay, andmammalian cell genemutation assay,
are summarized in Table 1.
2.1. Ames test
The Ames test is formally called the Salmonella typhimurium
reversion assay. This test is used worldwide as an initial
screen to determine themutagenic potential of agents and the
assay identifies point mutagens [12,13].
Four different types of TiO2-NPs have been evaluated by
the Ames assay and all of themwere negative in the standard
mutation assay. However, two showed positive responses
when evaluated with a modified fluctuation test procedure
(Table 1).
Jomini et al [14] used the standard fluctuation test and a
modified fluctuation test procedure with the S. typhimurium
strains TA97, TA98, TA100, and TA102 to measure the muta-
genic potential of two types of TiO2-NPs. The test was negativewhen thenormal assaywasused.However,when they applied
a simple pre-exposure of bacteria to the NPs in a low ionic
strength solution (NaCl, 10 mM) at a pH below the nano-
particles isoelectric points (pH 5.5), the results were positive.
They concluded that a simple pre-exposure step in a low ionic-
strength solution, at a pH below the nanoparticle isoelectric
points (NaCl, 10mM, pH 5.5) could increase bacterial uptake of
the nanoparticles and improve the accuracy of the test.
In another two tests, TiO2-NPs were negative in different
Salmonella strains. Landsiedel et al [15] evaluated several TiO2-
NPs used for sunscreen products using Ames test. S. typhi-
murium TA1535, TA100, TA1537, TA98, and TA102were treated
with the NPs at 20e5000 mg/plate both with or without meta-
bolic activation. No mutagenicity was found. In the other
study, the bacteria were preincubated with eight different
concentrations of 10 nm anatase TiO2-NPs up to 5000 mg/plate.
No mutation induction was found. Analyses with trans-
mission electron microscopy and energy-dispersive X-ray
spectroscopy show that the TiO2-NPs are not able to enter the
bacterial cells [16].
2.2. Comet assay
The Comet assay is a method for measuring DNA strand
breaks in eukaryotic cells. The Comet assay is also called the
single-cell gel electrophoresis assay due to its working prin-
ciple. After treatment, single cell suspensions are embedded
in agarose on a microscope slide and lysed. Electrophoresis at
high pH results in structures resembling comets when
observed by fluorescence microscopy. The intensity of the
comet tail relative to the head is proportional to the number of
DNA breaks. For detecting oxidative DNA damage, cells
embedded in agarose on microscope slides can be further
treated with nucleases such as formamidopyrimidine DNA-
glycosylase (Fpg), endonuclease III (Endo III), and 8-
hydroxyguanine DNA-glycosylase to generate secondary
DNA breaks at the sites with oxidative DNA adducts. The
Comet assay has been widely used to assess genotoxicity of
nanomaterials due to its sensitivity and simplicity. The results
from in vitro Comet assays on TiO2-NPs are summarized in
Table 1.
Among 24 Comet assay tests, 17 of them showed positive
responses to treatments of different types of TiO2-NPs (Table
1). Bottlenose dolphin leukocytes were treated with smaller
than 25 nm anatase TiO2-NPs and the Comet assay was per-
formed to measure the genotoxicity of the NPs. The results
showed that the NPs were genotoxic for the cells after expo-
sure to concentrations of 50 mg/mL and 100 mg/mL for 24 hours
and 48 hours, respectively [17]. AGS human gastric epithelial
cells treated with 21 nm TiO2-NPs caused DNA damage. The
tail intensity increased 1.88-fold in 150 mg/mL of TiO2-NPs
treated cells compared to the control cells [18]. Human pe-
ripheral blood lymphocytes and cultured human embryonic
kidney (HEK293) cells were treated with 1 mg/mL, 10 mg/mL,
and 100 mg/mL of 2.3 nm TiO2-NPs and the DNA breaks were
measured using the Comet assay with or without the Fpg and
Endo III enzymes. The 100 mg/mL of TiO2-NPs significantly
increase the DNA damagewith or without the Fpg and Endo III
enzymes in both the cell lines [19]. The Comet assays were
conducted using human bronchial epithelial BEAS 2B cells to
Table 1 e In vitro studies on genotoxicity of titanium dioxide nanoparticles.
Size and crystalline
structure
Dose Test system Result Author and Reference
Ames test
23 nm; 84% anatase
and 16% rutile
1e100 mg/mL A modified fluctuation test procedure
for the Ames test
Positive Jomini et al, 2012 [14]
5.7 nm; 86% anatase
and 14% brookite
1e100 mg/mL A modified fluctuation test procedure
for the Ames test
Positive Jomini et al, 2012 [14]
23 nm; 84% anatase
and 16% rutile
1e100 mg/mL Fluctuation Ames test Negative Jomini et al, 2012 [14]
5.7 nm; 86% anatase
and 14% brookite
1e100 mg/mL Fluctuation Ames test Negative Jomini et al, 2012 [14]
10  50 nm; rutile in T-Lite Up to 5 mg/plate Ames test Negative Landsiedel et al, 2010 [15]
10 nm; anatase 5 mg/plate Ames test Negative Woodruff et al, 2012 [16]
Comet assay
<25 nm; anatase 50 mg/mL and 100 mg/mL Bottlenose dolphin leukocytes Positive Bernardeschi et al, 2010 [17]
21 nm; 80%/20% anatase/rutile 150 mg/mL AGS human gastric epithelial cell line Positive Botelho et al, 2013 [18]
2.3 nm 100 mg/mL With or without Fpg and End III in Human
peripheral blood lymphocytes and cultured human
embryonic kidney cells (HEK293)
Positive Demir et al, 2013a [19]
50 nm 25 mg/mL Human lymphocytes Positive Ghosh et al, 2013 [21]
14 nm; anatase 50 mg/mL Syrian hamster embryo cells Positive Guichard et al, 2012 [22]
25 nm; 80%/20% anatase/rutile 10 mg/mL, 25 mg/mL, and 50 mg/mL Syrian hamster embryo cells Positive Guichard et al, 2012 [22]
5.9 nm; anatase 100 mg/mL Chinese hamster lung fibroblast cells Positive Hamzeh and Sunahara, 2013
[23]
34.1 nm; 83% anatase and
17% rutile
100 mg/mL Chinese hamster lung fibroblast cells Positive Hamzeh and Sunahara, 2013
[23]
1.5 nm; rutile 100 mg/mL Chinese hamster lung fibroblast cells Positive Hamzeh and Sunahara, 2013
[23]
Varying sizes 12e140 nm;
anatase or rutile
100 mg/mL A549 human lung carcinoma cells Positive Jugan et al, 2012 [24]
7 nm anatase or 10 nm rutile 0.5e256 mg/mL Human hepatoblastoma C3A cells Positive Kermanizadeh et al, 2012 [25]
27.5 nm; 86% anatase/14% rutile 20e100 mg/mL Human bronchial epithelial cell Positive Prasad et al, 2013 [26]
30 nm 20 mg/mL Human amnion epithelial (WISH) cells Positive Saquib et al, 2012 [27]
10 nm; anatase 0.8e80 mg/mL Human epidermal cells (A431) Positive Shukla et al, 2011 [29]
30e70 nm 1e80 mg/mL HepG2 cells Positive Shukla et al, 2013 [28]
<100 nm 3mM, 5 mM, and 10 mM Human peripheral blood lymphocytes Positive Turkez 2011 [30]
25 nm anatase; 25 nm 80%
anatase and 20% rutile
80 mg/mL, 120 mg/mL, and 150 mg/mL Human SHSY5Y neuronal cells Positive Valdiglesias et al, 2013 [31]
<100 nm anatase Up to 50 mg/cm2 Human lung fibroblasts and human bronchial
fibroblasts
Negative Bhattacharya et al, 2009 [32]
62 nm; rutile Up to 50 mg/mL Syrian hamster embryo cells Negative Guichard et al, 2012 [22]
15e30 nm; anatase 20e200 mg/mL Human peripheral blood lymphocytes Negative Hackenberg et al, 2011 [33]
1e10 nm; polyacrylate-coated 100 mg/mL Chinese hamster lung fibroblast cells Negative Hamzeh and Sunahara, 2013
[23]
10  50 nm; rutile in T-Lite Up to 600 mg/mL for 4 h exposure
and up to 150 mg/mL for 24 h exposure
V79 cells Negative Landsiedel et al, 2010 [15]
(continued on next page)
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Table 1 e (continued )
Size and crystalline
structure
Dose Test system Result Author and Reference
10 nm; anatase Up to 40 mg/mL Chinese hamster ovary cells (CHO-K1) Negative Wang et al, 2011 [34]
10 nm; anatase Up to 200 mg/mL TK6 human lymphocytes Negative Woodruff et al, 2012 [16]
Micronucleus assay
20 nm 0.5 mg/mL and 1 mg/mL Chinese hamster ovary cells Positive Di Virgilio et al, 2010 [35]
27.5 nm; 86% anatase/14% rutile 20e100 mg/mL Human bronchial epithelial cell Positive Prasad et al, 2013 [26]
20 nm 1.0 mg/cm2 Syrian hamster embryo cells Positive Rahman et al, 2002 [36]
30e70 nm 1e80 mg/mL HepG2 cells Positive Shukla et al, 2013 [28]
10 nm; anatase 0.8e80 mg/mL Human epidermal cells (A431) Positive Shukla et al, 2011 [29]
<25 nm 10 and 50 mg/mL Human lung cancer cells (A549) Positive Srivastava et al, 2011 [37];
Srivastava et al, 2013 [38]
21 nm; anatase; 5e125 mg/mL Human lymphocytes Positive Tavares et al, 2013 [39]
22 nm; hydrophobic rutile 5e125 mg/mL Human lymphocytes Positive Tavares et al, 2013 [39]
19 nm; hydrophilic rutile 5e125 mg/mL Human lymphocytes Positive Tavares et al, 2013 [39]
<100 nm 3 mM, 5 mM, and 10 mM Human peripheral blood lymphocytes Positive Turkez, 2008 [30]; Turkez, 2011
[51]
25 nm; anatase 80 mg/mL, 120 mg/mL, and 150 mg/mL Human SHSY5Y neuronal cells Positive Valdiglesias et al, 2013 [31]
25 nm; 80% anatase and 20% rutile 80 mg/mL, 120 mg/mL, and 150 mg/mL Human SHSY5Y neuronal cells Positive Valdiglesias et al, 2013 [31]
25 nm; 80% anatase and 20% rutile Up to 50 mg/mL Syrian hamster embryo cells Negative Guichard et al, 2012 [22]
14 nm; anatase Up to 50 mg/mL Syrian hamster embryo cells Negative Guichard et al, 2012 [22]
62 nm; rutile Up to 50 mg/mL Syrian hamster embryo cells Negative Guichard et al, 2012 [22]
20 nm; 85% anatase and 15% rutile Up to 250 mg/mL Human lymphocytes Negative Tavares et al, 2013 [39]
Sister chromatid exchange assay
20 nm 1e5 mg/mL Chinese hamster ovary cells Positive Di Virgilio et al, 2010 [35]
<100 nm 3mM, 5 mM and 10 mM Human peripheral blood lymphocytes Positive Turkez, 2008 [30]; Turkez, 2011
[51]
Hprt mutation assay
10 nm; anatase Up to 40 mg/mL Hprt mutation assay in Chinese hamster ovary cells (CHO-K1) Negative Wang et al, 2011 [34]
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and 10  40 nm SiO2-coated rutile TiO2-NPs. The results
showed that both the two types of TiO2-NPs induced DNA
breaks [20]. DNA fragmentation was induced by TiO2-NPs in
human lymphocytes at a concentration of 25 mg/mL [21].
Guichard et al [22] compared genotoxicity of nanosized and
non-nanosized anatase and rutile TiO2 particles in Syrian
hamster embryo (SHE) cells. Although TiO2-NPs in both forms
induced higher cytotoxicity than their bulk counterparts after
72 hours of exposure, the anatase NPs induced similar levels
of DNA damage in the Comet assay after 24 hours of exposure
as the bulk particles. Chinese hamster lung fibroblast cells
were treated with 100 mg/mL of 5.9 nm anatase, 34.1 nm 83%
anatase and 17% rutile mixture, and 1.5 nm rutile TiO2-NPs,
respectively. DNA double strand breaks were measured using
the Comet assay. All types of the NPs were positive in the test
[23]. Jugan et al [24] evaluated genotoxicity of varying sizes of
NPs in A549 human lung carcinoma cells and found that they
were genotoxic when assayed with the Comet assay.
Following 4 hours’ exposure of the human hepatoblastoma
C3A cells to sublethal levels of the TiO2-NPs, DNA damage
measured by the Comet assay was significantly induced [25].
Prasad et al [26] evaluated effects of TiO2-NP agglomeration on
their genotoxicity using three different nanoparticle-
treatment media. They found that TiO2-NPs induced similar
amounts of DNA damage measured by the Comet assay in all
three media, independent of the amount of agglomeration,
cellular interaction, or cell-cycle changes [26]. Human amnion
epithelial (WISH) cells were exposed to varying concentrations
of 30 nm TiO2-NPs for 6 hours. The comet results exhibited a
significant induction of DNA damage at 20 mg/mL of the par-
ticles [27]. TiO2-NPs (30e70 nm) induced significant oxidative
DNA damage in HepG2 cells measured with the Fpg-Comet
assay even at 1 mg/mL [28]. Human epidermal cells (A431)
were treated with 50 nm anatase TiO2-NPs at doses
0.008e80 mg/mL. The treatment resulted in a significant DNA
damage in the cells [29]. Human peripheral blood lymphocytes
were treated with 3 mM, 5 mM, and 10 mM TiO2-NPs (<100 nm).
DNA damage measured using the Comet assay was increased
by the treatment and addition of ascorbic acid prevented the
induction [30]. Two types of TiO2-NPs, 25-nm anatase and
25 nm with 80% anatase and 20% rutile, were used for the
treatment of human SHSY5Y neuronal cells. The Comet assay
was conducted after treatment for 3 hours or 6 hours of the
two types of particles. Positive results were obtained for both
types of NP [31].
Seven out of 24 Comet assay tests gave negative responses
to TiO2-NPs (Table 1). TiO2-NPs (anatase, <100 nm) did not
induce DNA-breakage measured by the Comet assay in
human lung fibroblasts and human bronchial fibroblasts [32].
Guichard et al [22] found that 60-nm rutile TiO2-NPs did not
increase DNA damage after 24 hours of exposure to SHE cells
at concentrations up to 50 mg/mL. Human peripheral blood
lymphocytes from 10 male donors were exposed to 15e30 nm
anatase TiO2-NPs at concentrations 20 mg/mL, 50 mg/mL,
100 mg/mL, and 200 mg/mL for 24 hours. Although the NPs were
detected in the cytoplasm and nucleus of the lymphocytes,
they did not induce genotoxicity in the cells measured with
the Comet assay [33]. Landsiedel et al [15] treated V79 cells
with 10 nm  50 nm rutile TiO2-NPs at concentrations up to600 mg/mL for 4 hours and up to 150 mg/mL for 24 hours’
exposure in T-Lite and measured the DNA damage with the
Comet assay. The result was negative for the test. Chinese
hamster lung fibroblast cells were treated with 1e10 nm
polyacrylate-coated TiO2-NPs and the Comet assay was per-
formed. The NPs were negative in the test [23]. Chinese
hamster ovary cells (CHOeK1) were exposed to < 25 nm
anatase TiO2-NPs at concentrations 0 mg/mL, 10 mg/mL, 20 mg/
mL, or 40 mg/mL for 60 days. Immediately after the treatment,
the alkaline Comet assay was performed and the result was
negative [34]. The genotoxicity of 10 nm anatase TiO2-NPs was
assessed with the Comet assay. TK6 cells were treated with
0e200 mg/mL TiO2-NPs for 24 hours. Although the TK6 cells did
take up the particles, no significant induction of DNA breakage
or oxidative DNA damage was observed in the treated cells
using the standard alkaline assay or the EndoIII and 8-
hydroxyguanine DNA-glycosylase-modified assay [16].
2.3. Micronucleus assay
Themicronucleus testmeasures damage to the chromosomes
andmitotic apparatus of cells. An increase in the frequency of
micronucleated cells is an indication of induced chromosome
damage. Studies on 16 types of TiO2-NPs using the micronu-
cleus assay are summarized in Table 1. Twelve of them were
positive in the test, and four were negative. Genotoxic effects
of 20 nm TiO2-NPs were evaluated using Chinese hamster
ovary (CHO-K1) cells. Micronucleus frequencies were signifi-
cantly increased by 0.5 mg/mL and 1 mg/mL of the NPs [35].
Human bronchial epithelial BEAS 2B cells were treated with
smaller than 25 nm uncoated anatase TiO2-NPs and
10 nm  40 nm SiO2-coated rutile TiO2-NPs, respectively.
Although the uncoated TiO2-NPs increased the micronucleus
frequency, the SiO2-coated NPs did not [20]. Guichard et al [22]
found that none of the TiO2-NPs or TiO2 bulk particles showed
significant induction of micronuclei formation after 24 hours’
exposure of these particles to SHE cells. Prasad et al [26] found
that TiO2-NPs induced micronuclei only in a medium that
facilitated the lowest amount of agglomeration, the greatest
amount of NP-cellular interaction, and the highest population
of cells accumulating in S phase. The genotoxic potential of
20 nm TiO2-NPs was assessed in SHE cells. The cells were
treated with 1.0 mg/cm2 of the particles for 12 hours, 24 hours,
48 hours, 66 hours, and 72 hours. The micronucleus fre-
quencies were increased by the treatment in a time-
dependent manner [36]. HepG2 cells were treated with low
doses of 30e70 nm TiO2-NPs and a significant increase in the
micronucleus frequencywas observed in the treated cells [28].
Human epidermal cells (A431) were treated with 50 nm
anatase TiO2-NPs at doses of 0.008e80 mg/mL. The treatment
resulted in significant chromosome alteration at doses
0.8e80 mg/mL [29]. Human lung cancer cells, A549, were
treated with 10 mg/mL and 50 mg/mL of TiO2-NPs for 24 hours.
Micronucleus assay was conducted to determine the geno-
toxicity of the particles and there was a positive response in
the micronucleus induction for both of the treatment con-
centrations [37,38]. Tavares et al [39] evaluated genotoxicity of
different types of TiO2-NPs using in vitro micronucleus assay
in human lymphocytes. They found that 21 nm anatase TiO2-
NPs at 125 mg/mL dose, 22 nm hydrophobic rutile TiO2-NPs at
j o u r n a l o f f o o d and d ru g an a l y s i s 2 2 ( 2 0 1 4 ) 9 5e1 0 41005 mg/mL and 45 mg/mL doses, and 19 nm hydrophilic rutile
TiO2-NPs at 15 mg/mL and 45 mg/mL doses significantly
increased the frequencies of micronucleated binucleated cells
except for 20 nm uncoated 15% rutile and 85% anatase TiO2-
NPs. Human peripheral blood lymphocytes were treated with
3 mM, 5 mM, and 10 mMTiO2-NPs (<100 nm). A positive response
of TiO2-NPs inmicronucleus assaywas found and the addition
of ascorbic acid decreased the micronucleus induction [30].
Human SHSY5Y neuronal cells were treated with 25 nm
anatase TiO2-NPs and 25 nm TiO2-NPs with 80% anatase and
20% rutile. Results from the micronucleus test showed that
both types of the TiO2-NPs induced a dose-dependent micro-
nucleus formation after 6 hours’ exposure [31].
2.4. SCE assay
The SCE assay is a short-term test for the detection of recip-
rocal exchanges of DNA between two sister chromatids of a
duplicating chromosome. A positive response of this assay
indicates certain types of chromosome damage. Only two
studies on SCE analysis of TiO2-NPs have been reported (Table
1). Genotoxic effects of 20 nm TiO2-NPs were evaluated by
conducting SCE assay in Chinese hamster ovary (CHOeK1)
cells. SCE frequencies were significantly increased by 1e5 mg/
mL of the TiO2-NPs [35]. In the second study, human periph-
eral blood lymphocytes were treated with 3 mM, 5 mM, and
10 mM TiO2-NPs (<100 nm). The SCE assay was conducted and
the genotoxicity of the NPs tested was positive. Addition of
ascorbic acid resulted in decreasing the SCE frequencies [30].
2.5. Mammalian cell mutation assay
The in vitro mammalian cell mutation assays detect gene
mutations induced by test agents. The most commonly-used
genes for measurement of mutations are the thymidine ki-
nase and hypoxanthine-guanine phosphoribosyl transferase
(Hprt) genes. The mutation tests detect different spectra of
mutational events. Only one in vitro mammalian cells muta-
tion study was found (Table 1). The Hprt gene mutation assay
was conducted on chronically exposed cells for 60 days to
0e40 mg/mL< 25 nm anatase TiO2-NPs. The results showed no
mutation induction [34].3. In vivo studies
The in vivo genotoxicity of TiO2-NPs has been investigated in
several studies (Table 2) using the in vivo Comet assay,
micronucleus assay, wing somatic mutation and recombina-
tion assay, and phosphatidylinositol glycan, class A gene (Pig-
a) mutation assay.
3.1. The in vivo Comet assay
Five studies have been performed using the in vivo Comet
assay in different tissues. Two showed positive responses to
TiO2-NP treatment. CBAB6F1 mice were treated via gavage
with 33 nm TiO2-NPs at doses of 40 mg/kg, 200 mg/kg, and
1000 mg/kg body weight, daily for 7 days. Genotoxic effects in
brain, liver, and bone marrow were evaluated by the Cometassay. The NPs induced DNA damage in bone marrow and
liver, but not in the brain [40]. In the other positive comet
study, mice were treated through drinking water containing a
21-nm mixture of 75% anatase and 25% rutile TiO2-NPs and
DNA damage measured by the Comet assay in the blood cells.
DNA strand breaks were significantly increased by 500 mg/kg
TiO2-NPs [41].
In the first negative study, rats were exposed by inhalation
with T-Lite SF containing 79e89% TiO2-NP (10 nm  50 nm
rutile) and T-Lite Max containing 69e73% TiO2-NPs, used as
UV protecting agents in sunscreens, and genotoxicity of the
particles were investigated in the lung by the in vivo Comet
assay. No DNA damage was found in the lung [15]. C57BL/6J
mice were treated with freshly generated TiO2-NPs (74%
anatase, 26% brookite at approximately 80 nm in size) for
5 days, 4 hours/day by inhalation at doses of 0.8 mg/m3,
7.2 mg/m3, and 28.5 mg/m3. DNA damage was assessed by the
Comet assay in lung epithelial alveolar type II and Clara cells
sampled immediately following the exposure. Although a
dose-dependent deposition of Ti in lung tissue was seen, no
significant effect was observed on the level of DNA damage in
lung epithelial cells [42]. The genotoxicity of 5 nm anatase
TiO2-NPs was evaluated using the Comet assay after a single
or repeated intratracheal instillation at doses of 1.0 mg/kg or
5.0 mg/kg body weight or 0.2 mg/kg or 1.0 mg/kg body weight
once a week for 5 weeks. The lung cells were used for the
assay and there was no increase in % tail DNA in any of the
treatment groups [43].
3.2. The in vivo micronucleus assay
Four in vivo micronucleus tests of TiO2-NPs have been re-
ported: one was positive and three of them were negative.
C57BL/6J mice were treated with NPs and micronuclei were
analyzed in peripheral blood polychromatic erythrocytes
(PCEs) collected 48 hours after the last exposure. No significant
effect on micronucleated PCEs was observed [42]. In vivo
micronucleus assay was conducted to evaluate the genotox-
icity of 10 nm TiO2 anatase NPs in mice. B6C3F1 mice were
treated intravenously for 3 consecutive days with 0.5 mg/kg,
5.0 mg/kg, and 50 mg/kg TiO2-NPs. The mouse blood was
assayed and no induction of micronuclei was found although
the NPs reached the bone marrow and induced cytotoxicity
[44]. Finally, there was no induction of micronuclei in the PCE
ofmice 14 days after a single intravenous injection of different
doses of 40 nm anatase TiO2-NPs [45].
3.3. In vivo mutation assay
Two studies have been reported on the mutagenicity of TiO2-
NPs in vivo and both of them had negative results. Drosophila
melanogaster third instar larvae were fed with the medium
containing 0.1e10 mM TiO2-NPs and the SMART assay was
conducted. The results showed no significant increases in the
frequency of all measured spots, indicating that these NPs
were not able to induce mutations or recombination [46]. The
Pig-a mutation assay was performed at different sampling
times after mice were treated with different doses of 10 nm
anatase TiO2-NPs. The NPs did not increase mutant frequency
in the gene at any time point or dose [44].
Table 2 e In vivo studies on genotoxicity of titanium dioxide nanoparticles.
Size and crystalline structure Dose Test system Result Reference
In vivo Comet assay
33 nm 40e1000 mg/kg CBAB6F1 mice were gavaged daily for 7 d, and their
bone marrow, liver and brain were assayed
Positive in bone marrow
and liver; negative in brain
Sycheva et al, 2011 [40]
21 nm; 75% anatase and 25% rutile 500 mg/kg Mice were exposed via drinking water for 5 d,
and their blood cells were used for the assay
Positive Trouiller et al, 2009 [41]
80 nm; 74% anatase and 26% brookite Up to 28.5 mg/m3 Rats were exposed via inhalation for 5 d, 4 h/d and
their lung cells were assayed
Negative Lindberg et al, 2012 [42]
10  50 nm; rutile in T-Lite 10 mg/kg Rats were exposed by inhalation, and their lung
cells were assayed
Negative Landsiedel et al, 2010 [15]
5 nm; anatase Up to 5 mg/kg Intratracheally exposure to male SpragueeDawley
rats, and the lung cells was assayed
Negative Naya et al, 2012 [43]
Micronucleus assay
21 nm; 75% anatase and 25% rutile 500 mg/kg Mice were exposed via drinking water for 5 d.
The mouse blood cells were tested
Positive Trouiller et al, 2009 [41]
80 nm; 74% anatase and 26% brookite Up to 28.5 mg/m3 Rats were exposed via inhalation for 5 d, 4 h/d.
The peripheral blood polychromatic erythrocytes
were tested
Negative Lindberg et al, 2012 [42]
10 nm; anatase Three daily dose of
50 mg/kg
Intravenously exposure to male B6C3F1 mice;
the blood cells was assayed
Negative Sadiq et al, 2012 [44]
40 nm; anatase Up to 1387 mg/kg One dose intravenous injection to mice, and the
blood cells were assayed
Negative Xu et al, 2013 [45]
Mutation assay
2.3 nm; anatase Fed, 0.1e10 mM Drosophila melanogaster, the wing somatic mutation
and recombination assay
Negative Demir et al, 2013b [46]
10 nm; anatase Three daily dose of
50 mg/kg
Intravenously exposure to male B6C3F1 mice and
Pig-a mutation assay in blood cells was conducted
Negative Sadiq et al, 2012 [44]
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of TiO2-NPs
4.1. Oxidative stress
A number of studies suggest that TiO2-NPs induce toxicity via
oxidative stress due to their relatively large surface area and
greater reactive activity than bulk TiO2 particles. Jugan et al
[24] found that TiO2-NPs caused an early intracellular accu-
mulation of reactive oxygen species (ROS) and that addition of
glutathione significantly reduced the ROS, suggesting that this
molecular antioxidant detoxified ROS overproduction caused
by TiO2-NPs. Evidence for the induction of oxidative damage
to DNA was also gained from the measurement of the level of
8-oxo-7,8-dihydro-20-deoxyguanosine [24]. TiO2-NPs induced
a significant reduction in mitochondrial dehydrogenase ac-
tivity in human lymphocytes, resulting in the generation of
ROS and an alteration of mitochondrial membrane potential
[21]. Bhattacharya et al [32] showed that TiO2-NPs were able to
generate free radicals and induce indirect genotoxicitymainly
by DNA-adduct formation.
However, Jugan et al [24] reported that if experiments were
processed in the dark to avoid any photocatalytic effects on
TiO2-NPs, ROS accumulation decreased, suggesting that TiO2-
NPs generated ROS in cells via photocatalysis.
4.2. Size, structure, and agglomeration effects
Smaller TiO2-NPs were more genotoxic than larger TiO2-NPs,
regardless of their crystalline phases. It is likely that the
smaller the NPs are, the easier for them to enter cells and
accumulate inside the cells, both in the cytoplasm and the
nucleus [47]. Some studies show that anatase NPs induce
more deleterious effects than rutile NPs because of the pho-
tocatalytic properties of anatase TiO2. TiO2-NPs forming large
agglomerates induced DNA damage in different cell lines,
whereas NPs that formed smaller agglomerates (200 nm) had
no effect on genotoxicity [48].
4.3. Effects on DNA repair, proliferation, and apoptosis
Evidence indicates that TiO2-NPs can impair cellular DNA
repair, by inactivation of both the NER and BER pathways. The
inactivation could result from structural modification of NER
and BER proteins by oxidation caused by TiO2-NPs induced
ROS accumulation. Protein oxidation/reduction has been
regarded as a critical mechanism for the modulation of repair
pathway. Botelho et al [18] reported that 21 nm TiO2-NPs
increased oxidative stress and cell proliferation, and
decreased apoptosis in the AGS human gastric epithelial cell
line. Huang et al [49] showed that short-term exposure to
TiO2-NPs enhanced cell proliferation, survival, ERK signaling
activation, and ROS production in cultured fibroblasts
whereas long-term exposure to TiO2 -NPs not only increased
cell survival and growth but also increased the numbers of
multinucleated cells and micronuclei. Their results suggest
that long-term exposure to TiO2-NPs disturbs cell cycle pro-
gression and genome segregation, leading to chromosomal
instability and cell transformation.5. Conclusions
As withmany other nanomaterials, controversial results have
been reported on the genotoxicity of TiO2-NPs. A large number
of tests on TiO2-NPs have been conducted and many have
detected positive responses. However, there remain clear in-
consistencies in the reported results. The conflicting results
reported from different studies could have arisen from in-
consistencies in characteristics of the test materials, such as
size, shape, and crystalline structure. The different results
may also have been a function of the different test systems
and different genotoxicity endpoints that have been
employed. Generally, in vitro systems for assessing genotox-
icity of TiO2-NPs generated more positive results than the
in vivo systems, whereas DNA and chromosome damage tests
generated more positive results than the assays measuring
gene mutations. Nearly all tests for the mutagenicity of TiO2-
NPs were negative, except for a few studies using the Ames
test, which has been suggested to be unsuitable for detecting
the genotoxicity of nanoparticles [50]. The available evidence
indicates that TiO2-NPs induce genotoxicity mainly via
generating oxidative stress in cells. The ROS generation is
dependent on the size, structure, and aggregation of the TiO2-
NPs. The oxidative stress produced by the NPs could affect
DNA repair, cell cycle progression, cell proliferation, and
apoptosis by affecting protein structure.Conflicts of interest
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